• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

离子表面活性剂对姜黄素纳米晶体抗电解质的去稳定机制。

Destabilization Mechanism of Ionic Surfactant on Curcumin Nanocrystal against Electrolytes.

作者信息

Rachmawati Heni, Rahma Annisa, Al Shaal Loaye, Müller Rainer H, Keck Cornelia M

机构信息

Pharmaceutics Research Group, School of Pharmacy, Bandung Institute of Technology, Bandung 40132, Indonesia.

Research Center for Nanosciences and Nanotechnology, Bandung Institute of Technology, Bandung 40132, Indonesia.

出版信息

Sci Pharm. 2016 Oct 18;84(4):685-693. doi: 10.3390/scipharm84040685.

DOI:10.3390/scipharm84040685
PMID:27763572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5198027/
Abstract

We have successfully developed curcumin nanosuspension intended for oral delivery. The main purpose is to improve bioavailability through enhancing its solubility. The nanoparticles were stabilized using various stabilizers, including polyvinyl pyrrolidone (PVP), polyvinyl alcohol (PVA), sodium carboxymethylcellulose (Na-CMC), d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS), and sodium dodecyl sulfate (SDS). The average diameter of particles, microscopic appearance, and sedimentation of each preparation was observed and compared. Each stabilizer demonstrated a different degree of inhibition of particle aggregation under electrolyte-containing simulated gastrointestinal (GIT) fluid. Non-ionic stabilizers (PVA, PVP, and TPGS) were shown to preserve the nanosuspension stability against electrolytes. In contrast, strong ionic surfactants such as SDS were found to be very sensitive to electrolytes. The results can provide useful information for the formulators to choose the most suitable stabilizers by considering the nature of stabilizers and physiological characteristics of the target site of the drug.

摘要

我们已成功开发出用于口服给药的姜黄素纳米混悬液。主要目的是通过提高其溶解度来改善生物利用度。使用包括聚乙烯吡咯烷酮(PVP)、聚乙烯醇(PVA)、羧甲基纤维素钠(Na-CMC)、d-α-生育酚聚乙二醇1000琥珀酸酯(TPGS)和十二烷基硫酸钠(SDS)在内的各种稳定剂使纳米颗粒稳定。观察并比较了每种制剂的颗粒平均直径、微观外观和沉降情况。在含电解质的模拟胃肠(GIT)液中,每种稳定剂对颗粒聚集的抑制程度不同。非离子型稳定剂(PVA、PVP和TPGS)显示出能保持纳米混悬液对电解质的稳定性。相比之下,发现强离子型表面活性剂如SDS对电解质非常敏感。这些结果可为配方设计师通过考虑稳定剂的性质和药物靶部位的生理特性来选择最合适的稳定剂提供有用信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982c/5198027/06f6091f72b7/scipharm-84-00685-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982c/5198027/c5ff60ca7fe0/scipharm-84-00685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982c/5198027/13665751e31c/scipharm-84-00685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982c/5198027/6d8bf49623e6/scipharm-84-00685-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982c/5198027/dff18de17db1/scipharm-84-00685-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982c/5198027/06f6091f72b7/scipharm-84-00685-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982c/5198027/c5ff60ca7fe0/scipharm-84-00685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982c/5198027/13665751e31c/scipharm-84-00685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982c/5198027/6d8bf49623e6/scipharm-84-00685-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982c/5198027/dff18de17db1/scipharm-84-00685-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982c/5198027/06f6091f72b7/scipharm-84-00685-g005.jpg

相似文献

1
Destabilization Mechanism of Ionic Surfactant on Curcumin Nanocrystal against Electrolytes.离子表面活性剂对姜黄素纳米晶体抗电解质的去稳定机制。
Sci Pharm. 2016 Oct 18;84(4):685-693. doi: 10.3390/scipharm84040685.
2
Development of curcumin nanocrystal: physical aspects.姜黄素纳米晶体的开发:物理方面。
J Pharm Sci. 2013 Jan;102(1):204-14. doi: 10.1002/jps.23335. Epub 2012 Oct 9.
3
Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate.由琥珀酸聚乙二醇1000维生素E/月桂醇硫酸酯钠稳定的穿心莲内酯无定形纳米混悬液的制备及其体外/体内评价
Int J Nanomedicine. 2017 Feb 7;12:1033-1046. doi: 10.2147/IJN.S120887. eCollection 2017.
4
Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.制备柚皮素表面活性剂稳定纳米混悬剂以克服其较差的理化性质和低口服生物利用度。
Phytomedicine. 2018 Feb 1;40:48-54. doi: 10.1016/j.phymed.2017.12.021. Epub 2017 Dec 20.
5
Development of a novel l-sulpiride-loaded quaternary microcapsule: Effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability.新型 l-舒必利载四方微囊的研制:TPGS 作为吸收增强剂对理化性质和口服生物利用度的影响。
Colloids Surf B Biointerfaces. 2016 Nov 1;147:250-257. doi: 10.1016/j.colsurfb.2016.08.010. Epub 2016 Aug 8.
6
Development of daidzein nanosuspensions: Preparation, characterization, in vitro evaluation, and pharmacokinetic analysis.大豆黄素纳米混悬剂的研制:制备、表征、体外评价及药代动力学分析。
Int J Pharm. 2019 Jul 20;566:67-76. doi: 10.1016/j.ijpharm.2019.05.051. Epub 2019 May 21.
7
The effect of surface treatment on the brain delivery of curcumin nanosuspension: in vitro and in vivo studies.表面处理对姜黄素纳米混悬液脑内递药的影响:体内外研究。
Int J Nanomedicine. 2019 Jul 19;14:5477-5490. doi: 10.2147/IJN.S199624. eCollection 2019.
8
Development and evaluation of TPGS/PVA-based nanosuspension for enhancing dissolution and oral bioavailability of ticagrelor.基于 TPGS/PVA 的纳米混悬剂的研制与评价:提高替格瑞洛的溶解性能和口服生物利用度。
Int J Pharm. 2020 May 15;581:119287. doi: 10.1016/j.ijpharm.2020.119287. Epub 2020 Mar 31.
9
Nanosuspension coated multiparticulates for controlled delivery of albendazole.载药纳米混悬剂多颗粒制剂用于阿苯达唑的控释给药。
Drug Dev Ind Pharm. 2021 Mar;47(3):367-376. doi: 10.1080/03639045.2021.1879830. Epub 2021 Mar 15.
10
Multiple Functions of D-α-Tocopherol Polyethylene Glycol 1000 Succinate (TPGS) as Curcumin Nanoparticle Stabilizer: In Vivo Kinetic Profile and Anti-Ulcerative Colitis Analysis in Animal Model.聚乙二醇1000琥珀酸维生素E(TPGS)作为姜黄素纳米颗粒稳定剂的多种功能:动物模型中的体内动力学特征及抗溃疡性结肠炎分析
Pharmaceutics. 2017 Jul 21;9(3):24. doi: 10.3390/pharmaceutics9030024.

引用本文的文献

1
Formulation, Optimization, and Ex vivo Permeation Study of Ritonavir-loaded Solid Lipid Nanoparticles.载利托那韦固体脂质纳米粒的处方、优化及体外渗透研究
Curr Pharm Des. 2025 Feb 25. doi: 10.2174/0113816128329768241230071303.
2
Nanocrystals for Intravenous Drug Delivery: Composition Development, Preparation Methods and Applications in Oncology.用于静脉给药的纳米晶体:成分研发、制备方法及其在肿瘤学中的应用
AAPS PharmSciTech. 2025 Feb 20;26(3):66. doi: 10.1208/s12249-025-03064-0.
3
Deferasirox Nanosuspension Loaded Dissolving Microneedles for Intradermal Delivery.

本文引用的文献

1
Investigation of the polyvinyl alcohol stabilization mechanism and adsorption properties on the surface of ternary mixed nanooxide AST 50 (AlO-SiO-TiO).聚乙烯醇在三元混合纳米氧化物AST 50(AlO-SiO-TiO)表面的稳定机理及吸附性能研究。
J Nanopart Res. 2015;17(1):12. doi: 10.1007/s11051-014-2831-2. Epub 2015 Jan 11.
2
Application of the zeta potential measurements to explanation of colloidal CrO stability mechanism in the presence of the ionic polyamino acids.ζ电位测量在解释离子型聚氨基酸存在下胶体CrO稳定性机制中的应用。
Colloid Polym Sci. 2014;292(10):2453-2464. doi: 10.1007/s00396-014-3276-y. Epub 2014 Jun 4.
3
用于皮内给药的载去铁胺纳米混悬液的溶蚀性微针
Pharmaceutics. 2022 Dec 15;14(12):2817. doi: 10.3390/pharmaceutics14122817.
4
Drug Delivery Strategies for Curcumin and Other Natural Nrf2 Modulators of Oxidative Stress-Related Diseases.姜黄素及其他氧化应激相关疾病的天然Nrf2调节剂的药物递送策略
Pharmaceutics. 2021 Dec 12;13(12):2137. doi: 10.3390/pharmaceutics13122137.
5
Are lipid nanoparticles really superior? A holistic proof of concept study.脂质纳米粒真的更优越吗?整体概念验证研究。
Drug Deliv Transl Res. 2022 Jun;12(6):1433-1444. doi: 10.1007/s13346-021-01021-5. Epub 2021 Sep 3.
6
Progress in the development of stabilization strategies for nanocrystal preparations.纳米晶体制剂稳定策略的发展进展。
Drug Deliv. 2021 Dec;28(1):19-36. doi: 10.1080/10717544.2020.1856224.
7
PlantCrystals-Nanosized Plant Material for Improved Bioefficacy of Medical Plants.植物晶体——用于提高药用植物生物功效的纳米级植物材料。
Materials (Basel). 2020 Sep 30;13(19):4368. doi: 10.3390/ma13194368.
8
Acyclovir-Loaded Solid Lipid Nanoparticles: Optimization, Characterization and Evaluation of Its Pharmacokinetic Profile.载阿昔洛韦固体脂质纳米粒:优化、表征及其药代动力学特征评价
Nanomaterials (Basel). 2020 Sep 9;10(9):1785. doi: 10.3390/nano10091785.
9
Quality by Design Optimization of Cold Sonochemical Synthesis of Zidovudine-Lamivudine Nanosuspensions.齐多夫定-拉米夫定纳米混悬液冷超声化学合成的质量源于设计优化
Pharmaceutics. 2020 Apr 17;12(4):367. doi: 10.3390/pharmaceutics12040367.
10
Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign.瑞舒伐他汀钙纳米粒:通过制剂和稳定性协同设计提高生物利用度。
PLoS One. 2018 Jul 9;13(7):e0200218. doi: 10.1371/journal.pone.0200218. eCollection 2018.
Sodium dodecyl sulfate adsorption onto positively charged surfaces: monolayer formation with opposing headgroup orientations.
十二烷基硫酸钠在带正电荷表面上的吸附:头基取向相反的单层形成。
Langmuir. 2013 Oct 15;29(41):12710-9. doi: 10.1021/la401119p. Epub 2013 Oct 1.
4
Development of curcumin nanocrystal: physical aspects.姜黄素纳米晶体的开发:物理方面。
J Pharm Sci. 2013 Jan;102(1):204-14. doi: 10.1002/jps.23335. Epub 2012 Oct 9.
5
Immobilization of mercury in field soil and sediment using carboxymethyl cellulose stabilized iron sulfide nanoparticles.利用羧甲基纤维素稳定的硫化铁纳米颗粒固定田间土壤和沉积物中的汞。
Nanotechnology. 2012 Jul 27;23(29):294007. doi: 10.1088/0957-4484/23/29/294007. Epub 2012 Jun 28.
6
Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion.醋酸纤维素固体分散体提高难溶性药物姜黄素的生物利用度。
AAPS PharmSciTech. 2012 Mar;13(1):159-66. doi: 10.1208/s12249-011-9732-9. Epub 2011 Dec 16.
7
Stabilization of curcumin by complexation with divalent cations in glycerol/water system.甘油/水体系中二价阳离子与姜黄素形成复合物使其稳定。
Bioinorg Chem Appl. 2010;2010:292760. doi: 10.1155/2010/292760. Epub 2010 Jun 16.
8
Characteristics of polymers enabling nano-comminution of water-insoluble drugs.可实现水不溶性药物纳米粉碎的聚合物特性。
Int J Pharm. 2008 May 1;355(1-2):328-36. doi: 10.1016/j.ijpharm.2007.12.032. Epub 2007 Dec 28.
9
Interaction forces between particles stabilized by a hydrophobically modified inulin surfactant.由疏水改性菊粉表面活性剂稳定的颗粒间的相互作用力。
J Colloid Interface Sci. 2007 Jul 15;311(2):430-7. doi: 10.1016/j.jcis.2007.03.011. Epub 2007 Mar 15.
10
Investigation on the flow behavior of dispersions of solid triglyceride nanoparticles.
Int J Pharm. 2004 Oct 13;284(1-2):123-31. doi: 10.1016/j.ijpharm.2004.07.017.